Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00668083 | Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer(Sorse) | completed | — | 214 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 |
| NCT00692874 | Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy(AZTEK EXT) | completed | — | 1,646 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT01116154 | Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma | terminated | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Dec 9, 2010 | clinicaltrials |
| NCT01250483 | Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | completed | — | 174 | Seoul National University HospitalOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00966095 | PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy(PReCISE) | unknown | — | 1,200 | Source MDxINDUSTRY | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT00002881 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00816452 | Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer(InoPro) | completed | — | 180 | SanofiINDUSTRY | 1 | Nov 3, 2010 | clinicaltrials |
| NCT00005947 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 127 | DendreonINDUSTRY | 1 | Nov 1, 2010 | clinicaltrials |
| NCT01224405 | Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy(PON-PC-02) | unknown | Phase 3 | 600 | University of Turin, ItalyOTHER | 1 | Oct 20, 2010 | clinicaltrials |
| NCT00541788 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | completed | Phase 1 | 10 | University Hospital, GhentOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT00952666 | Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy | terminated | Early Phase 1 | 6 | Johns Hopkins UniversityOTHER | 1 | Sep 13, 2010 | clinicaltrials |
| NCT00630799 | Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients | terminated | Phase 3 | 20 | GP-PharmINDUSTRY | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00598312 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | completed | Phase 3 | 201 | Oakwood Laboratories, LLCINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00065442 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | completed | Phase 3 | 512 | DendreonINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00355758 | UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling | terminated | — | 200 | University of California, IrvineOTHER | 1 | Sep 1, 2010 | clinicaltrials |
| NCT00201916 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | completed | Phase 3 | 936 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00004014 | Liposomal Doxorubicin in Treating Patients With Prostate Cancer | completed | Phase 2 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01168323 | Spaced Education to Optimize Prostate Cancer Screening | completed | N/A | 95 | Harvard University Faculty of MedicineOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00982800 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | completed | Phase 4 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 6, 2010 | clinicaltrials |
| NCT00430235 | A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer | completed | Phase 2 | 39 | British Columbia Cancer AgencyOTHER | 1 | Aug 5, 2010 | clinicaltrials |
| NCT00193193 | Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00193232 | Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT01168141 | Window Study of ZD4054 in Metastatic Prostate Cancer | unknown | N/A | 30 | The Christie NHS Foundation TrustOTHER | 1 | Jul 23, 2010 | clinicaltrials |
| NCT00242060 | Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy | completed | N/A | — | University Health Network, TorontoOTHER | 1 | Jul 15, 2010 | clinicaltrials |
| NCT01025479 | Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent | completed | — | 829 | AstraZenecaINDUSTRY | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00269555 | Effects of GCP on Prostate Cancer. | completed | N/A | 62 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00305929 | Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | completed | Phase 2 | 8 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00312442 | Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy | terminated | Phase 2 / Phase 3 | 16 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00181558 | Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | completed | Phase 2 | 44 | Massachusetts General HospitalOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00681694 | Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer | unknown | — | 414 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2010 | clinicaltrials |
| NCT00258765 | Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. | terminated | Phase 2 | 1 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00871585 | Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide | completed | — | 340 | AstraZenecaINDUSTRY | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00908674 | Androcur Effects on Quality of Life | completed | — | 245 | BayerINDUSTRY | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00557037 | A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer | completed | Phase 2 | 60 | MEI Pharma, Inc.INDUSTRY | 1 | Apr 8, 2010 | clinicaltrials |
| NCT01089881 | The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Mar 19, 2010 | clinicaltrials |
| NCT00003307 | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | completed | Phase 2 | 25 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer(ZANTE) | completed | Phase 1 | 36 | National Cancer Institute, NaplesOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084526 | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00523484 | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts(CHAMPION) | completed | — | 1,200 | AstraZenecaINDUSTRY | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00811876 | Retrospective, Non-interventional Study of Depo-Eligard®.(OCT) | completed | — | 140 | Astellas Pharma IncINDUSTRY | 1 | Jan 22, 2010 | clinicaltrials |
| NCT00196807 | Prostate Cancer Screening: Fostering Informed Decisions | completed | Phase 3 | 543 | Georgetown UniversityOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00196781 | Treatment Decision Making in Early-Stage Prostate Cancer | completed | Phase 3 | 168 | Georgetown UniversityOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00176527 | Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 2 | 40 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Dec 11, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 10, 2010source: clinicaltrials